Related Experiment Video
Updated: Aug 7, 2026

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
Published on: May 31, 2018
Monocyte tissue factor induction by lipopolysaccharide (LPS): dependence on LPS-binding protein and CD14, and
K Mészáros1, S Aberle, R Dedrick
1XOMA Corp, Berkeley, CA 94710.
Abstract:
Mononuclear phagocytes, stimulated by bacterial lipopolysaccharide (LPS), have been implicated in the activation of coagulation in sepsis and endotoxemia. In monocytes LPS induces the synthesis of tissue factor (TF) which, assembled with factor VII, initiates the blood coagulation cascades. In this study we investigated the mechanism of LPS recognition by monocytes, and the consequent expression of TF mRNA and TF activity. We also studied the inhibition of these effects of LPS by rBPI23, a 23-kD recombinant fragment of bactericidal/permeability increasing protein, which has been shown to antagonize LPS in vitro and in vivo. Human peripheral blood mononuclear cells, or monocytes isolated by adherence, were stimulated with Escherichia coli O113 LPS at physiologically relevant concentrations (> or = 10 pg/mL). The effect of LPS was dependent on the presence of the serum protein LBP (lipopolysaccharide-binding protein), as shown by the potentiating effect of human recombinant LBP or serum. Furthermore, recognition of low amounts of LPS by monocytes was also dependent on CD14 receptors, because monoclonal antibodies against CD14 greatly reduced the LPS sensitivity of monocytes in the presence of serum or rLBP. Induction of TF activity and mRNA expression by LPS were inhibited by rBPI23. The expression of tumor necrosis factor showed qualitatively similar changes. Considering the involvement of LPS-induced TF in the potentially lethal intravascular coagulation in sepsis, inhibition of TF induction by rBPI23 may be of therapeutic benefit.
Insights
Bacterial lipopolysaccharide (LPS) triggers tissue factor (TF) in monocytes, initiating coagulation in sepsis. Recombinant bactericidal/permeability-increasing protein (rBPI23) inhibits this LPS-induced TF expression, offering potential therapeutic benefits for sepsis-related coagulation disorders.
Area of Science:
- Immunology
- Hematology
- Molecular Biology
Background:
- Mononuclear phagocytes play a key role in sepsis and endotoxemia by activating coagulation.
- Bacterial lipopolysaccharide (LPS) stimulates monocytes to synthesize tissue factor (TF), initiating the coagulation cascade.
- TF-initiated coagulation is a critical factor in the pathophysiology of sepsis.
Purpose of the Study:
- To elucidate the mechanism of LPS recognition by monocytes.
- To investigate the consequent expression of TF mRNA and TF activity.
- To evaluate the inhibitory effect of rBPI23 on LPS-induced TF expression.
Main Methods:
- Human peripheral blood mononuclear cells or isolated monocytes were stimulated with Escherichia coli O113 LPS.
- The role of lipopolysaccharide-binding protein (LBP) and CD14 receptors in LPS recognition was assessed.
- TF activity, TF mRNA expression, and tumor necrosis factor expression were measured.
- The inhibitory effects of rBPI23 were evaluated.
Main Results:
- LPS-induced effects were dependent on the presence of lipopolysaccharide-binding protein (LBP) and CD14 receptors.
- Recombinant bactericidal/permeability-increasing protein (rBPI23) significantly inhibited LPS-induced TF activity and mRNA expression.
- Tumor necrosis factor expression showed similar changes qualitatively.
Conclusions:
- Monocyte recognition of LPS involves LBP and CD14.
- rBPI23 effectively inhibits LPS-induced TF expression in monocytes.
- Inhibition of LPS-induced TF by rBPI23 may offer a therapeutic strategy for sepsis-related intravascular coagulation.
Related Concept Videos
Formation of Lipopolysaccharides
Bacterial Toxins

